Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 2 |
2023 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Stocky/Packed Pancreas: A Case of Focal Drug-Induced Acute Pancreatitis Mimicking Cancer.
Tomography. 2022 Aug 19;8(4):2073-2082. doi: 10.3390/tomography8040174.
Tomography. 2022.
PMID: 36006072
Free PMC article.
Survival analyses of the ZeOxaNMulti trial: Follow-up randomized, double-blinded, placebo-controlled trial of oral PMA-zeolite to prevent chemotherapy-induced side effects, especially peripheral neuropathy.
Vitale MG, Crispo A, Arundine D, Ronga R, Barbato C, Luongo A, Habetswallner F, De Martino BM, Maione A, Eisenwagen S, Vitale G, Riccardi F.
Vitale MG, et al. Among authors: arundine d.
Front Pharmacol. 2022 Nov 8;13:874028. doi: 10.3389/fphar.2022.874028. eCollection 2022.
Front Pharmacol. 2022.
PMID: 36425572
Free PMC article.
Item in Clipboard
Folinic acid in colorectal cancer: esquire or fellow knight? Real-world results from a mono institutional, retrospective study.
Romano FJ, Barbato C, Biglietto M, Di Lauro V, Arundine D, Fiorentino R, Ambrosio F, Cammarota M, Chiurazzi B, Puglia L, Scagliarini S, Ruocco R, Mocerino C, Cerillo I, Brangi MF, Riccardi F.
Romano FJ, et al. Among authors: arundine d.
Oncotarget. 2021 Feb 2;12(3):221-229. doi: 10.18632/oncotarget.27872. eCollection 2021 Feb 2.
Oncotarget. 2021.
PMID: 33613849
Free PMC article.
Item in Clipboard
Neutrophil-to-Lymphocyte Ratio Is a Major Prognostic Factor in Non-small Cell Lung Carcinoma Patients Undergoing First Line Immunotherapy With Pembrolizumab.
Romano FJ, Ronga R, Ambrosio F, Arundine D, Longo V, Galetta D, Gridelli C, Maione P, Palma V, Damiano V, Verde A, Giacobbe I, Augurio MR, Iengo G, Chetta M, Tarsitano M, Campione S, Failla G, Raucci A, Riccardi F.
Romano FJ, et al. Among authors: arundine d.
Cancer Diagn Progn. 2023 Jan 3;3(1):44-52. doi: 10.21873/cdp.10178. eCollection 2023 Jan-Feb.
Cancer Diagn Progn. 2023.
PMID: 36632583
Free PMC article.
Item in Clipboard
Cite
Cite